Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 2
1986 2
1987 3
1989 2
1990 5
1991 7
1992 4
1993 6
1994 7
1995 7
1996 12
1997 11
1998 1
1999 14
2000 13
2001 6
2002 10
2003 25
2004 16
2005 15
2006 19
2007 24
2008 24
2009 22
2010 49
2011 56
2012 37
2013 65
2014 64
2015 103
2016 109
2017 121
2018 150
2019 149
2020 195
2021 214
2022 93
Text availability
Article attribute
Article type
Publication date

Search Results

1,521 results
Results by year
Filters applied: . Clear all
Page 1
Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-κB repressing factor.
Chen XJ, Zhang WN, Chen B, Xi WD, Lu Y, Huang JY, Wang YY, Long J, Wu SF, Zhang YX, Wang S, Li SX, Yin T, Lu M, Xi XD, Li JM, Wang KK, Chen Z, Chen SJ. Chen XJ, et al. Among authors: xi xd. Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2220-2225. doi: 10.1073/pnas.1818539116. Epub 2019 Jan 18. Proc Natl Acad Sci U S A. 2019. PMID: 30659143 Free PMC article.
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
Zhang L, Huang Y, Hong S, Yang Y, Yu G, Jia J, Peng P, Wu X, Lin Q, Xi X, Peng J, Xu M, Chen D, Lu X, Wang R, Cao X, Chen X, Lin Z, Xiong J, Lin Q, Xie C, Li Z, Pan J, Li J, Wu S, Lian Y, Yang Q, Zhao C. Zhang L, et al. Among authors: xi x. Lancet. 2016 Oct 15;388(10054):1883-1892. doi: 10.1016/S0140-6736(16)31388-5. Epub 2016 Aug 23. Lancet. 2016. PMID: 27567279 Clinical Trial.
Ginsenosides: A Potential Neuroprotective Agent.
Zheng M, Xin Y, Li Y, Xu F, Xi X, Guo H, Cui X, Cao H, Zhang X, Han C. Zheng M, et al. Among authors: xi x. Biomed Res Int. 2018 May 8;2018:8174345. doi: 10.1155/2018/8174345. eCollection 2018. Biomed Res Int. 2018. PMID: 29854792 Free PMC article. Review.
1,521 results